Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
IHFvsIHEETF Comparison
iShares U.S. Healthcare Providers ETF (IHF) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. Both IHF and IHE have the same Total Expense Ratio (TER) of 0.38%. IHF is down -7.95% year-to-date (YTD) with +$19M in YTD flows. IHE performs better with 4.3% YTD performance, and +$129M in YTD flows. Run a side-by-side ETF comparison of IHF and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
IHF vs IHE performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHF IHE | -3.00%-1.82% | -9.66%+5.93% | -7.95%+4.30% | -12.82%+28.47% | -6.63%+63.32% | -6.51%+61.21% |
| Flows | IHF IHE | -$2M+$9M | +$5M+$154M | +$19M+$129M | +$94M+$248M | -$484M+$359M | -$353M+$393M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHF IHE | +25.28%+15.86% | +24.09%+20.40% | +19.04%+15.94% | +18.81%+15.80% |
| Max drawdown | IHF IHE | -12.35%-4.49% | -25.18%-14.18% | -29.86%-16.04% | -29.86%-16.12% |
| Max drawdown duration | IHF IHE | 64d10d | 332d150d | 554d210d | 554d669d |
IHF | IHE | |
Last sale 3/12/2026 at 2:17 PM | $44.38 | $87.05 |
| Previous close 03/11/2026 | $44.15 | $88.40 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IHF | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IHF | IHE | |
|---|---|---|
| Last price | $44.38 | $87.05 |
| 1D performance | +0.52% | -1.53% |
| AuM | $699.61 M | $1.02 B |
| E/R | 0.38% | 0.38% |
IHF | IHE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | iShares |
| Benchmark | Dow Jones U.S. Select Health Care Providers Index | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 54 | 46 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | May 1, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the IHF and IHE ETFs performed in 2026?
As of March 11, 2026, IHF is down -7.95% year-to-date (YTD), while IHE has returned 4.3%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: IHF or IHE?
Year-to-date, the IHF ETF saw +$19M in flows, compared to +$129M for IHE.
Which ETF is more volatile: IHF or IHE?
Over the past year, IHF had a volatility of 24.09%, while IHE experienced 20.4%.
Which ETF is bigger: IHF or IHE?
As of March 11, 2026, IHF holds $699.61 M in assets under management (AUM), while IHE manages $1.02 B.
What sectors do the IHF and IHE ETFs invest in?
IHF leans toward sectors like Health Care. Meanwhile, IHE focuses on Health Care.
What are the top holdings of the IHF ETF and IHE ETF?
IHF top holdings include UNITEDHEALTH GRP, CVS HEALTH CORP and ELEVANCE HEALTH INC. IHE holds in its top three: JOHNSON&JOHNSON, LILLY and MERCK & CO INC.
Which ETF is more diversified: IHF or IHE?
IHF holds 63 securities with 82.41% of its assets in the top 15. IHE has 56 securities and a top 15 weight of 84.8%.
Healthcare Stocks Drop on Medicare Payment Rate Surprise
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
Healthcare Stocks Rebound
Investing in the Aging Demographics Megatrend
Health is Wealth: A look at the Healthcare Sector
Health is Wealth: A look at the Healthcare Sector
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
